MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    Changes in motor subtype designation of early Parkinson’s disease patients

    R. Eisinger, D. Martinez-Ramirez, C. Hess, M. Okun, A. Gunduz (Gainesville, FL, USA)

    Objective: To examine changes in the designation of motor subtypes in Parkinson's disease (PD) patients within five years of diagnosis. Background: Distinct motor subtypes of…
  • 2017 International Congress

    Parkinson’s disease subtypes correlate with clinical severity: a Brazilian population study

    C. Batista, M. Medeiros, C. Rieder, A. Schuh (Porto Alegre, Brazil)

    Objective: To correlate Parkinson's disease (PD) subtypes with a clinical severity in a Brazilian population sample. Background: Current studies have shown that PD may comprise…
  • 2017 International Congress

    Baseline predictors for clinical progression after 48 month follow-up in early Parkinson’s disease from the DeNoPa cohort

    B. Mollenhauer, J. Zimmermann, F. Sixel-Döring, N. Focke, T. Wicke, J. Ebentheuer, M. Schaumburg, E. Lang, C. Trenkwalder (Kassel, Germany)

    Objective: To analyze clinical progression at enrolment in drug-naïve Parkinson’s disease (PD) subjects over 48 months of follow-up, we describe the annual rate of progression…
  • 2017 International Congress

    Some clincal features of movement disorders after cerebral anoxia.

    B. Tserensodnom (Ulaanbaatar, Mongolia)

    Objective: To describe some clinical features of movement disorders after cerebral anoxia. Background: The basal ganglia, especially the globi pallidi (GP), are highly vulnerable to…
  • 2017 International Congress

    Wearing Off Frequency in Different Hoehn-Yahr Stages in Parkinson’s Disease

    H. Cotur Levent, E. Bayram, M. Akbostanci (Ankara, Turkey)

    Objective: To determine wearing off frequency in different stages of Parkinson’s disease (PD). Background: Levodopa is the gold standard in the symptomatic treatment of PD. The…
  • 2017 International Congress

    Gait Asymmetry and Parkinson’s Disease

    C. Ashton, L. Solis-Cohen, L. Wagenaar, R. Laracuente, E. Sorberg, V. Vanderhorst, L. Shih (Boston, MA, USA)

    Objective: To evaluate gait asymmetry using velocity-dependent gait analysis and compare to UPDRS asymmetries. Background: Motor impairment, including gait impairment, in patients with Parkinson’s disease…
  • 2017 International Congress

    Movement disorder specialists’ determination of eligibility for device aided treatment in advanced Parkinson’s disease: Results from the OBSERVE-PD study

    A. Fasano, K. Seppi, V.SC. Fung, J.C. Parra, L. Bergmann, A. Yegin, K. Sail, Y. Jalundhwala, K. Onuk (Toronto, ON, Canada)

    Objective: To characterize the clinical and non-clinical features of ‘advanced’ PD patients considered to be eligible or ineligible for device-aided treatment (DAT) options by movement…
  • 2017 International Congress

    Impaired sensorimotor and visual networks in drug naive Parkinson’s disease based on graph theoretical analysis

    H. Chen (Beijing, China)

    Objective: We aim to investigate topographic structure in drug naive patients with Parkinson’s disease (PD). Background: Resting state functional magnetic resonance imaging (rs-fMRI) provides valuable…
  • 2017 International Congress

    Associations of DAT SPECT and TCS with prodromal features of Parkinson’s disease: results in PREDICT-PD participants

    A. Noyce, J. Dickson, J. Bestwick, I. Isaias, M. Politis, G. Giovannoni, T. Warner, A. Lees, A. Schrag (London, United Kingdom)

    Objective: To examine whether changes on dopamine reuptake transporter (DAT) SPECT and transcranial sonography (TCS) correlated with Parkinson’s disease (PD) risk scores and other prodromal…
  • 2017 International Congress

    Connectivity patterns in frontal cognitive regions in Parkinson’s disease

    A. Hanganu, A. Nagano-Saito, A. Tam, N. Auclair-Ouellet, S. Jobert, B. Mejia-Constain, D. Schoemaker, C. Degroot, A.-L. Lafontaine, H. Chertkow, P. Bellec, O. Monchi (Calgary, AB, Canada)

    Objective: Evaluate the changes in brain connectivity between Parkinson’s disease (PD) with and without mild cognitive impairment (MCI). Background: Up to 40% of PD patients…
  • « Previous Page
  • 1
  • …
  • 320
  • 321
  • 322
  • 323
  • 324
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley